Defining the Boundaries of Addiction: A Biological Perspective

1 / 28
About This Presentation
Title:

Defining the Boundaries of Addiction: A Biological Perspective

Description:

Explore the Boundaries of Addiction - Are Pathological Gambling (PG) and Other ... Ventral Tegmental Area, Nucleus Accumbens. Frontal Serotonin Systems ('Bad Brakes' ... – PowerPoint PPT presentation

Number of Views:195
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: Defining the Boundaries of Addiction: A Biological Perspective


1
Defining the Boundaries of Addiction A
Biological Perspective
  • Marc N. Potenza, M.D., Ph.D.
  • Associate Professor of Psychiatry
  • Director, Problem Gambling Clinic
  • Director, Women and Addictions Core,
  • Womens Health Research at Yale
  • Director of Neuroimaging, VA VISN1
  • MIRECC, West Haven VA Hospital
  • Yale University School of Medicine

3rd Mind World Conference, May 4, 2007
2
Overview
  • Explore the Boundaries of Addiction - Are
    Pathological Gambling (PG) and Other Impulse
    Control Disorders (ICDs) Behavioral Addictions?
  • Examine the Relationship Between PG, Substance
    Use Disorders (SUDs) and Other Mental Health
    Disorders
  • Describe the Clinical Implications (Prevention,
    Treatment) of Conceptualizing PG and Other ICDs
    as Behavioral Addictions

3rd Mind World Conference, May 4, 2007
3
What is Addiction?
  • Addict (verb) - to devote or give (oneself)
    habitually or compulsively from Latin addicere
    - bound to or enslaved
  • Historical Shifts in Usage of Term
  • Core Components of Addiction (Shaffer, 1999)
  • - Continued Behavior Despite Adverse Consequences
  • - Diminished or Lost Control / Compulsive
    Engagement
  • - Craving or Urge State Component

3rd Mind World Conference, May 4, 2007
4
Addiction As a Disorder of Motivation
  • The Study of Obesity, Pathological Gambling, and
    Other Motivated States Associated With Or Leading
    to Compulsive Behavior Will Provide An
    Opportunity to Learn About the Possible
    Predispositions and Variations in the Reward
    Circuit That Lead to Uncontrollable, Compulsive
    Behavior, Independent of Direct Pharmacological
    Activation of Brain Reward Circuits (NIDA,
    Neuron, 2002)

3rd Mind World Conference, May 4, 2007
5
What is Gambling?
  • Gambling Is Placing Something of Value at Risk in
    Hopes of Achieving Something of Greater Value
    (Potenza et al, JAMA, 2001)
  • Perception Influenced by the Relative Amounts of
    Risk and Reward
  • - Mutual Funds Vs. Day Trading

3rd Mind World Conference, May 4, 2007
6
A Gambling Spectrum
  • Non-gambling lt-gt Recreational Gambling lt-gt
    Problem Gambling lt-gt Pathological Gambling
  • Recreational Gamblers Constitute a Majority
  • Health Associations of Specific Levels of
    Gambling Incompletely Understood
  • - Problem and Pathological Gambling Appear Most
    Disruptive and Costly on a Per Capita Basis

3rd Mind World Conference, May 4, 2007
7
Gambling Impact Behavior Study
  • Problem and Pathological Gambling Are Associated
    with High Rates of
  • - Divorce
  • - Poor General Health
  • - Mental Health Problems
  • - Job Loss and Lost Wages
  • - Bankruptcy
  • - Arrest and Incarceration
  • Problem Pathological Gambling Associated w/
    Estimated Annual Societal Cost of 5 Billion

3rd Mind World Conference, May 4, 2007
8
When Is Gambling a Problem?
  • Pathological Gambling (PG) (Level 3)
  • - Most Disordered Form of Gambling
  • - DSM-IV-TR Disorder
  • - Analogous to Substance Dependence
  • Problem Gambling (Level 2)
  • - Widely Used But Not a DSM-IV-TR Disorder
  • - Analogous to Substance Abuse

3rd Mind World Conference, May 4, 2007
9
Impulse Control Disorders As Behavioral
Addictions
  • ICDs Not Elsewhere Classified
  • - Pathological Gambling, Kleptomania, Pyromania,
    Intermittent Explosive Disorder,
    Trichotillomania, ICD NOS
  • ICDs Under Consideration
  • - Compulsive Buying, Compulsive Sexual Behavior,
    Compulsive Computer Use
  • ICDs Common in Hospitalized Psychiatric Pts
  • - Among 204 Adult In-pts, 31 Had a Current ICD,
    with lt2 Diagnosed Upon Admission (Grant et al,
    Am J Psych, 2005)
  • Among 102 Patients Adolescent In-pts, 40 Had a
    Current ICD, with lt1 Dxed Upon Admission
    (Grant et al, J Clin Psych, in press)

3rd Mind World Conference, May 4, 2007
10
Frequencies of ICDs in Adult Psychiatric
Inpatients
  • Past-Year Lifetime
  • Compulsive Buying 9.3 9.3
  • Kleptomania 7.8 9.3
  • Pathological Gambling 6.9 6.9
  • Intermittent Explosive D/O 6.4 6.9
  • Compulsive Sexual Behaviors 4.4 4.9
  • Pyromania 3.4 5.9
  • Trichotillomania 3.4 4.4

Grant et al, Am J Psychiatry, 2005
3rd Mind World Conference, May 4, 2007
11
Psychiatric Diagnoses and ICDs
  • No Differences in Admission Diagnoses for Mood,
    Psychotic or Substance Use Disorders Between
    Adult Pts with an ICD Vs. Those Without
  • Adults With an ICD More Likely (Trend) To Have
    Multiple non-ICD Diagnoses (62.7 vs. 49.6
    plt0.08)
  • Among Adolescents, ICD Presence was Associated
    with Internalizing Disorders (78.0 vs. 55.7
    plt0.02) and Prior Hospitalization (75.6 vs.
    41.0 plt0.001)
  • Adolescents As Compared with Adults Showed
    Different Patterns of ICDs, with Intermittent
    Explosive Disorder Being Most Common (12.7 of
    Sample)

Grant et al, AJP, 2005 JCP, in press
3rd Mind World Conference, May 4, 2007
12
PG and Co-Occurring Disorders
  • Rec Gam Vs Prob Gam
  • Disorder Non Gam Vs Non Gam
  • Major Depression 1.7 (1.1, 2.6) 3.3 (1.6, 6.8)
  • Dysthymia 1.8 (1.0, 3.0) 2.1 (0.8, 5.7)
  • Schizophrenia 0.6 (0.2, 1.8) 3.5 (1.3, 9.7)
  • Phobias 1.2 (0.9, 1.7) 2.3 (1.2, 4.3)
  • Somatization 1.7 (1.1, 2.8) 3.0 (1.6, 5.8)
  • Antisocial PD 2.3 (1.6, 3.4) 6.1 (3.2, 11.6)
  • Alcohol Use 3.9 (2.4, 6.3) 7.2 (2.3, 23.0)
  • Alcohol Abuse/Dep 1.9 (1.3, 2.7) 3.3 (1.9,
    5.6)
  • Nicotine Use 1.9 (1.6, 2.4) 2.6 (1.6, 4.4)
  • Nicotine Dep 1.3 (1.0, 1.7) 2.1 (1.1, 3.8)
  • NS Mania, Suicidality, OCD, Panic, GAD, Drug
    Use, Drug Abuse/Dep
  • plt0.05

3rd Mind World Conference, May 4, 2007
Source Cunningham-Williams et al, 1998
13
Relationship Between PG and SUDs
  • High Rates of Co-Occurrence
  • - Population and Clinical Samples
  • Similar Clinical Courses
  • - High Rates in Adolescence, Lower Rates in Older
    Adults
  • - Telescoping Pattern in Women
  • Similar Clinical Characteristics
  • - Tolerance, Withdrawal, Repeated Attempts to Cut
    Back or Quit
  • - Appetitive Urge or Craving States
  • Similar Biologies
  • - Genetic Contributions, Neural Circuits
  • Similar Treatments
  • - Self-Help, CBT, MI, Naltrexone and Nalmefene

3rd Mind World Conference, May 4, 2007
14
Clinical Relevance of PG SUDs
  • Individuals with Co-Occurring PG and SUDs
    Experience More Severe Symptoms Than Those With
    SUDs Alone (Kaplan Davis, 1997)
  • - Increased Rates of Admission for Detoxification
    (gt Two-Fold Rate)
  • - Increased Rates of Admission for Psychiatric
    Stabilization (gt 50 Increased Rate)
  • - More Suicidality (Federman et al, 1998)

3rd Mind World Conference, May 4, 2007
15
Motivation in Addiction
  • Motivated Behaviors Become Increasingly Limited
    Over Time to Addiction-Related Actions
  • Neural System Abnormalities Underlying Motivated
    Behaviors in Addiction Represent Important
    Targets for Treatment
  • Motivational Neurocircuitry Differences Are
    Likely Present At Specific Stages of Addiction
  • - Impulsive Decision-Making (Early ( Late)) vs.
    Compulsive Engagement (Late)

3rd Mind World Conference, May 4, 2007
16
Impulsivity as an Endophenotype
  • Defining Impulsivity (Moeller et al, 2001)
  • - A Predisposition Toward Rapid, Unplanned
    Reactions to Internal or External Stimuli With
    Diminished Regard to the Negative Consequences
    of These Reactions to the Impulsive Individual or
    to Others
  • Impulsivity Across Psychiatric Groups
  • - ICDs, SUDs, Bipolar D/O, ADHD, ASPD, BPD,
    Suicidality, SIB
  • Behavioral Measures of Impulsivity
  • - Risk/Reward Assessment Decision-Making
    Paradigms (Monetary Reward/Punishment,
    Discounting, Gambling Tasks)
  • - Response Disinhibition/Attentional Paradigms
    (Go/No-Go, Stroop)

3rd Mind World Conference, May 4, 2007
17
Neural Systems and Addiction
  • Mesocorticolimbic Dopamine System (Overactive
    Motor)
  • - Ventral Tegmental Area, Nucleus Accumbens
  • Frontal Serotonin Systems (Bad Brakes)
  • - Frontal/Prefrontal Cortical Function
  • Role for Neurotransmitter Systems Modulating DA,
    5HT Function
  • - GABA, Glutamate, Opioids, ...

3rd Mind World Conference, May 4, 2007
18
Roles for Neurotransmitters
  • Neurotransmitter Role in Impulse Control
  • Norepinephrine (NE) Arousal, Excitement
  • Serotonin (5HT) Behavior Initiation/Cessation
  • Dopamine (DA) Reward, Reinforcement
  • Opioids Pleasure, Urges

Potenza and Hollander, 2002
3rd Mind World Conference, May 4, 2007
19
5-HT Impulse Control
  • Low CSF 5-HIAA Associated w/ Impaired Impulse
    Control (Potenza and Hollander, 2002)
  • Altered Biochemical and Behavioral Responses to
    m-CPP (5HT1R and 5HT2R Partial Agonist) (DeCaria
    et al, 1998)
  • Blunted 5HT Response in vmPFC in Impulsive
    Aggression (Siever et al, 1999 New et al, 2002)

3rd Mind World Conference, May 4, 2007
20
Impulsivity and Addiction
  • Serotonergic Drugs (e.g., SSRIs) Have Shown Mixed
    Results in the Tx of PG (Grant et al, 2003)
  • SSRI Tx May Be Particularly Effective for
    Particular Groups of Individuals with PG
  • Individuals with PG and Co-Occurring Affective
    Disorders (Grant and Potenza, 2006a)

3rd Mind World Conference, May 4, 2007
21
Decision-Making, Reward Processing and Addiction
  • Individuals with PG or SUDs Perform
    Disadvantageously or Impulsively on Gambling
    Tasks, and Performance Correlates with Real-Life
    Measures (Petry et al, 2001 Bechara, 2003)
  • Individuals with PG or SUDs Discount Rewards
    Rapidly Over Time (Bickel et al, 1999 Petry et
    al, 2001)
  • Behavioral Measures of Reward Discounting Are
    Associated with SUD Tx Outcome (Krishnan-Sarin et
    al, 2007)

3rd Mind World Conference, May 4, 2007
22
Reward Processing in Addiction
  • Adults w/ AD vs Those w/o AD Show Less Activation
    of NAc in Anticipation of Working for Monetary
    Reward (Hommer et al, 2004)
  • Similar Findings in Adolescents and Adults FH
    Vs. FH- for AD (Hommer et al, 2004)
  • Extends Across Addictions - Less Activation of
    NAc in PG vs. Control During Monetary Wins vs.
    Losses (Reuter et al, 2005)

3rd Mind World Conference, May 4, 2007
23
Dopamine and ICDs in PD
  • PG and Other ICDs Reported in Association with
    Parkinsons Disease (Dodd et al, 2005)
  • Association Linked to Dopamine Agonist Treatment
    (Weintraub Potenza, 2006)
  • Prior ICD and FH of EtOHism Associated with ICD
    Presence in PD (Weintraub et al, 2006 Voon et
    al, 2006)
  • Need to Identify Neurobiological Factors
    Underlying Vulnerability to ICDs in PD

3rd Mind World Conference, May 4, 2007
24
Genetics of PG, AD and AAB
  • Shared Genetic Contributions to PG and AD
  • - 12-20 of Genetic Variation in the Risk for PG
    Accounted for by the Risk for AD (Slutske et al,
    2000)
  • Shared Genetic Contributions to PG and AAB
  • - 16-22 of Genetic Variation in the Risk for PG
    Accounted for by the Risk for Anti-Social
    Behaviors (Slutske et al, 2001)
  • Shared Risks Suggest Shared Genetic Contributions
    to Risk for Impulsiveness

3rd Mind World Conference, May 4, 2007
25
Pharmacological Treatment of AD
  • FDA-Approved Drugs for AD (None for PG)
  • - Disulfiram, Naltrexone, Acamprosate
  • Naltrexone and Other Opioid Antagonists
    Indirectly Modulate Dopamine Neurotransmission in
    VTA-NAc Pathway
  • Might Naltrexone or Other Mu-Opioid Receptor
    Antagonists Be Effective in Treating PG?

3rd Mind World Conference, May 4, 2007
26
Opioid Antagonists
  • High-Dose Naltrexone (Avg Dose 188 mg/day)
    Effective in Targeting PG Sxs (Kim et al, 2001)
  • High Rates of Drop-Out LFT Abnormalities
  • Greater Drug-Related Improvement in Subjects with
    High Initial Gambling Urge Measures
  • - Similar to Naltrexone Cravings in AD
  • Encouraging Findings with Opioid Antagonist
    Nalmefene (Grant et al, 2006)

3rd Mind World Conference, May 4, 2007
27
Association Between PG and MD in VET Sample
Variable OR (95 CI) p-value Alcohol
Abuse/Dependence 2.7 (1.5, 4.7) 0.001 Drug
Abuse/Dependence 1.9 (1.0, 3.3) 0.04 Antisocial
Personality D/O 2.5 (1.1, 5.5) 0.02 Generalized
Anxiety D/O 3.0 (1.3, 6.5) 0.007 Major
Depression 2.0 (1.1, 3.4) 0.02 NS Age,
Income, HS Education, College Education, Nicotine
Dependence, PTSD, Panic D/O Unadjusted OR for MD
4.1 (2.6-6.5) OR for MD Adjusting for
Sociodemographics 4.1 (2.6-6.5)
28
Bivariate Biometric Model for PG MD
Potenza et al, 2005, Arch Gen Psychiatry
29
Overall Conclusions
  • PG and Other ICDs Are Common, Particularly Among
    Psychiatric Pts
  • There Exist Multiple Shared Features Between ICDs
    and SUDs
  • Characterizing Biological Mechanisms of ICDs Has
    Implications for Categorizing Disorders and Tx
    Development
  • Identification of PG and Other ICDs Critical For
    Optimizing Clinical Care

3rd Mind World Conference, May 4, 2007
30
The International Society for Research on
Impulsivity and Impulse Control Disorders (ISRI)
www.impulsivity. org (or contact
marc.potenza_at_yale.edu)
Write a Comment
User Comments (0)